Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-octadecanaminium, N,n-dimethyl-n-octadecyl-
2. Ddbas Compound
3. Dimethyl-dioctadecyl-ammonium Bromide
4. Dimethyldioctadecylammonium
5. Dimethyldioctadecylammonium Chloride
6. Dimethyldioctadecylammonium Methyl Sulfate
7. Dimethyldioctadecylammonium Sulfate
8. Dimethyldistearylammonium
9. Dimethyldistearylammonium Bisulfate
10. Dimethyldistearylammonium Bromide
11. Dioctadecyl Dimethylammonium Bromide
12. Dioctadecyldimethylammonium
13. Dioctadecyldimethylammonium Chloride
14. Dioctadecyldimethylammonium Ion
15. Distearyl Dimethyl Ammonium Bromide
16. Distearyldimethylammonium
17. Distearyldimethylammonium Bromide
18. Distearyldimonium
19. Distearyldimonium Chloride
20. Dodab
21. Dsdac Cpd
1. 3700-67-2
2. N,n-dimethyl-n-octadecyloctadecan-1-aminium Bromide
3. 1-octadecanaminium, N,n-dimethyl-n-octadecyl-, Bromide
4. Dimethyl(dioctadecyl)azanium;bromide
5. Distearyldimethylammonium Bromide
6. Distearyl Dimethyl Ammonium Bromide
7. Dioctadecyldimethylammonium Bromide
8. Z5t47r065a
9. 1-octadecanaminium, N,n-dimethyl-n-octadecyl-, Bromide (1:1)
10. Dimethyldistearylammonium Bromide
11. Dsab
12. Einecs 223-037-6
13. Mfcd00041975
14. Unii-z5t47r065a
15. Dimethyldioctadecylazanium Bromide
16. Dsdmab
17. Schembl25636
18. Distearyldimonium Bromide
19. Dtxsid60884005
20. Dimethyl-dioctadecyl-azanium Bromide
21. Dimethyldioctadecylammonium (bromide)
22. Di-n-octadecyldimethylammonium Bromide
23. Akos015833037
24. As-62181
25. Da-17512
26. N,n-distearyl-n,n-dimethylammonium Bromide
27. Bis(octadecyl)dimethylammonium Bromide
28. Cs-0128789
29. D1975
30. Ft-0625134
31. D89966
32. W-106572
33. Q27295043
34. 18:0 Ddab, Dimethyldioctadecylammonium (bromide Salt), Powder
35. 18:0 Ddab, Dimethyldioctadecylammonium (bromide Salt), Chloroform
| Molecular Weight | 631.0 g/mol |
|---|---|
| Molecular Formula | C38H80BrN |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 34 |
| Exact Mass | 629.54741 g/mol |
| Monoisotopic Mass | 629.54741 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 391 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Surface-Active Agents
Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
ABOUT THIS PAGE
39
PharmaCompass offers a list of Dimethyldioctadecylammonium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Dimethyldioctadecylammonium manufacturer or Dimethyldioctadecylammonium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dimethyldioctadecylammonium manufacturer or Dimethyldioctadecylammonium supplier.
A D2779_SIGMA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D2779_SIGMA, including repackagers and relabelers. The FDA regulates D2779_SIGMA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D2779_SIGMA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A D2779_SIGMA supplier is an individual or a company that provides D2779_SIGMA active pharmaceutical ingredient (API) or D2779_SIGMA finished formulations upon request. The D2779_SIGMA suppliers may include D2779_SIGMA API manufacturers, exporters, distributors and traders.
click here to find a list of D2779_SIGMA suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A D2779_SIGMA DMF (Drug Master File) is a document detailing the whole manufacturing process of D2779_SIGMA active pharmaceutical ingredient (API) in detail. Different forms of D2779_SIGMA DMFs exist exist since differing nations have different regulations, such as D2779_SIGMA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A D2779_SIGMA DMF submitted to regulatory agencies in the US is known as a USDMF. D2779_SIGMA USDMF includes data on D2779_SIGMA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The D2779_SIGMA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of D2779_SIGMA suppliers with USDMF on PharmaCompass.
D2779_SIGMA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D2779_SIGMA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right D2779_SIGMA GMP manufacturer or D2779_SIGMA GMP API supplier for your needs.
A D2779_SIGMA CoA (Certificate of Analysis) is a formal document that attests to D2779_SIGMA's compliance with D2779_SIGMA specifications and serves as a tool for batch-level quality control.
D2779_SIGMA CoA mostly includes findings from lab analyses of a specific batch. For each D2779_SIGMA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D2779_SIGMA may be tested according to a variety of international standards, such as European Pharmacopoeia (D2779_SIGMA EP), D2779_SIGMA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D2779_SIGMA USP).
